Opus Genetics, Inc.: 10-Q filed 2019-11-06

Name: Opus Genetics, Inc.: 10-Q filed 2019-11-06
Creator: Opus Genetics, Inc.

What Opus Genetics, Inc. reported in its quarterly report filed 2019-11-06 (fiscal Q3 2019): 29 published measures, 72 facts as tagged in accession 0001140361-19-019932.

This filing

Form: 10-Q (quarterly report)
Filed: 2019-11-06
Fiscal period: fiscal Q3 2019
Accession: 0001140361-19-019932 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Opus Genetics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2019-09-30	14,980,776	USD
At 2018-12-31	16,042,926	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2019-09-30	3,225,536	USD
At 2018-12-31	5,480,036	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2019-09-30	11,755,240	USD
At 2019-06-30	13,623,106	USD
At 2018-12-31	10,562,890	USD
At 2018-09-30	6,411,895	USD
At 2018-06-30	11,423,264	USD
At 2017-12-31	16,768,596	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	-1,959,230	USD	92
2019-01-01 to 2019-09-30	-6,766,510	USD	273
2018-07-01 to 2018-09-30	-5,338,819	USD	92
2018-01-01 to 2018-09-30	-11,251,960	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2019-01-01 to 2019-09-30	-8,564,580	USD	273
2018-01-01 to 2018-09-30	-14,218,428	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2019-01-01 to 2019-09-30	7,653,828	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2019-01-01 to 2019-09-30	98,551	USD	273
2018-01-01 to 2018-09-30	9,910,996	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-09-30	-161,453,752	USD
At 2018-12-31	-154,687,242	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-09-30	85,302	USD
At 2018-12-31	112,473	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2019-01-01 to 2019-09-30	379,348	USD	273
2018-01-01 to 2018-09-30	845,210	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	-2,280,624	USD	92
2019-01-01 to 2019-09-30	-9,206,793	USD	273
2018-07-01 to 2018-09-30	-4,683,907	USD	92
2018-01-01 to 2018-09-30	-15,571,203	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-09-30	14,635,857	USD
At 2018-12-31	15,899,668	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-09-30	3,001,267	USD
At 2018-12-31	3,152,550	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	2,280,624	USD	92
2019-01-01 to 2019-09-30	9,206,793	USD	273
2018-07-01 to 2018-09-30	4,683,907	USD	92
2018-01-01 to 2018-09-30	15,571,203	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	1,131,418	USD	92
2019-01-01 to 2019-09-30	5,022,049	USD	273
2018-07-01 to 2018-09-30	2,887,955	USD	92
2018-01-01 to 2018-09-30	10,379,081	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2019-09-30	4,019,141	shares
At 2018-12-31	3,122,843	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2019-09-30	7,932,100	USD
At 2018-12-31	8,744,301	USD
At 2018-09-30	4,591,722	USD
At 2017-12-31	8,899,154	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2019-09-30	7,848	USD
At 2018-12-31	-17,836	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2019-09-30	233,936	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2019-09-30	235,449	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2019-09-30	362,925	USD
At 2018-12-31	821,590	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2019-09-30	277,623	USD
At 2018-12-31	709,117	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2019-09-30	722,217	USD
At 2018-12-31	1,173,847	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2019-09-30	1,500,000	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	-1,958,561	USD	92
2019-01-01 to 2019-09-30	-6,740,826	USD	273
2018-07-01 to 2018-09-30	-5,303,351	USD	92
2018-01-01 to 2018-09-30	-11,224,561	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	1,149,206	USD	92
2019-01-01 to 2019-09-30	4,184,744	USD	273
2018-07-01 to 2018-09-30	1,795,952	USD	92
2018-01-01 to 2018-09-30	5,192,122	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2019-07-01 to 2019-09-30	321,394	USD	92
2019-01-01 to 2019-09-30	2,440,283	USD	273
2018-07-01 to 2018-09-30	-654,912	USD	92
2018-01-01 to 2018-09-30	4,319,243	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2019-01-01 to 2019-09-30	7,653,828	USD	273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2019-01-01 to 2019-09-30	158,962	USD	273

Inspect the source

Entity: Opus Genetics, Inc. / CIK 0001228627
Captured: 2026-09-20T07:46:24.028Z
SEC response SHA-256: 59b3f548361fa5c66fb8bd927bac9bc7dc8822bcce158860c7c4d77974af0a92

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001228627.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))